[{"id":"cachexia-appetite-pharmacotherapy","kind":"technology","name":"Cachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine","route":"/technologies/cachexia-appetite-pharmacotherapy/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/nutrition.ts","type":"changed","fields":[{"field":"tldr","before":"\"Three drug approaches to cancer wasting: a new antibody that blocks the hormone suppressing appetite, an appetite hormone mimic approved only in Japan, and a very cheap old tablet. None is yet standard everywhere; al...","after":"\"Cachexia pharmacotherapy covers three drug approaches to cancer wasting: a new antibody that blocks the hormone suppressing appetite, an appetite hormone mimic approved only in Japan, and a very cheap old tablet. Non..."}]},{"id":"cachexia-appetite-pharmacotherapy","kind":"technology","name":"Cachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine","route":"/technologies/cachexia-appetite-pharmacotherapy/","commit":"dd90cde211","date":"2026-09-08","author":"Jude Gomila","message":"Diet, exercise and lifestyle front content","file":"src/data/nutrition.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"sections"},{"field":"status"},{"field":"wikipedia"},{"field":"tldr"},{"field":"summary"},{"field":"principle"},{"field":"strengths"},{"field":"limitations"},{"field":"cancers"},{"field":"technologies"},{"field":"drugs"},{"field":"terms"},{"field":"trials"},{"field":"pathways"},{"field":"companies"},{"field":"institutions"},{"field":"people"},{"field":"bottlenecks"},{"field":"related"},{"field":"links"}]}]